Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Dr Mojtaba Aghaei, Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Iran

Mojtaba Aghaei is a Master of Science and Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Iran. 🌟 Specializing in Hematology, Blood Banking, Cancer Therapy, and Cell Signaling, Mojtaba’s research focuses on genetic variants, diabetes mellitus, and chronic lymphoblastic leukemia. 🧬 His projects include systematic reviews and meta-analyses on topics such as advanced glycation end products in PCOS, and the impact of sulfur dioxide on semen quality. With 50 citations and ongoing research on ischemia-modified albumin, his work advances understanding in hematology and endocrinology. 📊🔬

Publication profile

Google scholar

Academic and Professional

Mojtaba Aghaei is a Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, specializing in Hematology, Blood Banking, and Cancer Therapy. His expertise extends to Cancer Cell Signaling, Flow Cytometry, Cell Culture, Endocrinology, and Gynecology.

Research Projects

Recent studies have explored various aspects of health and disease through systematic reviews and meta-analyses. 🧬 Key areas include the impact of genetic variants on antifungal immunity in hematologic malignancies, associations between Galectin-3 and gestational diabetes, and the role of advanced glycation end products in polycystic ovary syndrome (PCOS). 🔬 Research also investigates the effects of environmental pollutants on semen quality and the influence of biomarkers like Pro-BNP on cardiac health. 📊 Additionally, studies address the correlation between eosinophils and IgE in asthma, and factors influencing acute chest syndrome and thrombotic purpura in sickle cell disease. 🌍💉

Research focus

Based on the provided publications, the research focus of SS Bahreiny appears to be on reproductive health, particularly in the context of polycystic ovary syndrome (PCOS) and male fertility. The systematic reviews and meta-analyses span various aspects, such as oxidative stress, hormonal imbalances, and genetic factors related to PCOS, as well as environmental influences on semen quality. This research aims to understand and improve the diagnosis and treatment of reproductive disorders through comprehensive analyses of circulating biomarkers and environmental impacts. 🧬🔬🩺

Publication top notes

Association of free radical product and polycystic ovary syndrome: A systematic review and meta-analysis

Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis

Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis

The influence of CDKAL1 (rs7754840) gene polymorphism on susceptibility to gestational diabetes mellitus in pregnant women: A systematic review and meta-analysis

Association between ambient particulate matter and semen quality parameters: a systematic review and meta-analysis

Exploring the relationship between ambient sulfur dioxide and semen quality parameters: A systematic review and meta-analysis

Circulating levels of advanced glycation end products in females with polycystic ovary syndrome: a meta-analysis

Genetic Variants of Dectin-1 and their antifungal immunity impact in Hematologic Malignancies: A Comprehensive Systematic Review

A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Education

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊